Golden Helix, Inc.

Unlock the power of structural variant analysis with our latest blog post! Discover how the Breakends Table in VarSeq simplifies the identification and interpretation of structural variants, making your research more efficient and accurate. Don't miss out on this deep dive into innovative genetic research tools! Read more here: https://bit.ly/3VLrYBn #Genetics #Genomics #StructuralVariants #VarSeq #GoldenHelix #GeneticResearch #Bioinformatics

Discover how VarSeq is at the forefront of genetic innovation and discovery. Our latest blog highlights recent publications that showcase the power of VarSeq in advancing genetic research. Dive in and explore the future of genomics! Read more here: https://bit.ly/3VZ3FBo #GeneticResearch #VarSeq #Innovation #Genomics #GoldenHelix

Did you know that Golden Helix has a pharmacogenomics solution now? We have added VSPGx to our software suite as a pharmacogenomics interpretation software based on the CPIC recommendations. This PGx variant detection and recommendation software identifies diplotypes and annotates them with drug recommendations. If you are seeking out a PGx analysis and interpretation software, head to our site to learn more: https://bit.ly/4bMrFh7 #PGx #Pharmacogenetics #Bioinformatics #NGS #PrecisionMedicine

The VarSeq Suite recently became CE marked to meet the European In Vitro Diagnostic Regulation (IVDR 2017/746) requirements. We also recently received ISO 13485:2016 certification for our Medical Devices and Quality Management Systems. With these two regulatory certifications, we offer you #VarSeqDx, our flagship software designed with compliance and reliability for your clinical NGS analysis. To learn more and request a demo, please follow the link here: https://bit.ly/3WBU18A #IVD #IVDR #EEA #NGS #PrecisionMedicine #VarSeq #ISO

Check out our latest webcast on PGx Analysis in VarSeq: A User's Perspective. Discover how VarSeq streamlines pharmacogenomics analysis with expert insights and real-world applications. Watch the recording here: https://bit.ly/4eukewa #GoldenHelix #VarSeq #Pharmacogenomics #PGx #Genomics #Webcast #Bioinformatics

We’re thrilled to announce that the recording of our Corporate Satellite Meeting at ESHG 2024 is now available! We proudly presented this in conjunction with Twist Bioscience and PacBio who offered insights into whole-exome sequencing and long-read data. Dive into our latest advancements in genomic analysis and discover how Golden Helix is pioneering the future of precision medicine. Don’t miss out on this opportunity to learn from the experts. Watch now! #ESHG2024 #Genomics #WholeExomeSequencing #PrecisionMedicine

Golden Helix has been honored by @Life Sciences Review! We are thrilled to announce that our dedication to innovation and excellence in the field of NGS has been recognized. This award is a testament to our team's hard work and commitment to advancing genomic analysis. Thank you to all our customers, partners, and supporters for being a part of this journey. We couldn't have achieved this without you! Learn more: https://bit.ly/3z7GRX2 Stay tuned as we continue to lead the way in providing cutting-edge solutions for genomic research. #GoldenHelix #LifeSciencesReview #Innovation #Genomics #Award #Excellence

Join us for our upcoming webcast next Wednesday! We will be discussing our release of the PGx capabilities in VarSeq and the following: -Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis. -Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting. Click the link to learn more and register! #PrecisionMedicine #Pharmacogenetics #PGx #Genetics #VarSeq

On Tues., May 7, 2024, Bozeman-based Golden Helix, Inc. announced that it received CE mark approval for its genetic analysis platform VarSeq Suite. This significant regulatory milestone paves the way for the expansion of Golden Helix's advanced genetic analytics products to the European market. "Obtaining the CE mark is a pivotal step for Golden Helix as we expand internationally," said Dr. Andreas Scherer, president and CEO of Golden Helix. "This approval not only demonstrates our commitment to compliance and quality. It enhances our ability to serve healthcare providers with advanced genetic testing solutions that improve patient outcomes." Learn more: https://bit.ly/3QP0l8R #MHTBAMemberNews #PressReleases #biotech #bioscience #Bozeman #EU

At Golden Helix, we're committed to empowering researchers with the best tools and insights. Our latest blog explores the intricacies of CNV metrics in VarSeq. Learn more and elevate your CNV calling today! https://bit.ly/3VADmRV #Genetics #Bioinformatics #DataAnalysis